Researchers developed an AI-based deep learning model that uses retinal images to detect early-stage Alzheimer’s disease and mild cognitive impairment with high accuracy, offering a noninvasive, cost-effective screening tool.
3 Ways for Government to Help Spur Biomedical Innovation
Margaret Anderson, Managing Director at Deloitte Consulting LLP In response to the COVID-19 pandemic, the biomedical community took on the task of developing and deploying